07/08/2024 - Press release
A 10% increase in blood sugar levels from the usual raises the likelihood of a poor prognosis by 7% and the chance of death by 10% within three months of the stroke, according to a study published in Cardiovascular Diabetology. The study reviewed data from nearly 3,000 patients treated for this condition at Hospital del Mar. Research will continue to determine if managing glucose levels in this population can improve their prognosis.
Més informació "Higher Glucose Levels Worsen Prognosis in Ischemic Stroke Patients"
23/07/2024 - Press release
Chest ultrasound enables quick and easy identification of patients who may have a worse prognosis due to pneumonia caused by SARS-CoV-2 infection. The published work is a collaboration between Hospital del Mar and Doctors Without Borders, published in the Journal of Clinical Medicine. This diagnostic tool, with proper training and access to portable ultrasound devices, is particularly useful in resource-limited countries due to its ease of bedside use.
10/07/2024 - Press release
A study published in Science Advances identifies a set of microproteins that are exclusively produced in liver tumors. This makes them a clear target for immune system cells and a potential target for cancer vaccine development. The research was led by the Evolutionary Genomics Research Group at the Hospital del Mar Research Institute, in collaboration with Cima University of Navarra and Pompeu Fabra University. Various state-of-the-art tools were used to detect and identify these small molecules in samples from over a hundred tumors.
Més informació "Microproteins Found in Tumors Could Lead to Cancer Vaccines"
12/07/2024 - Press release
The new method would allow for a more objective and precise classification of patients' types of osteoarthritis, supported by data mining techniques and biological modeling, which enable the analysis and processing of large volumes of information. Pompeu Fabra University (UPF) and Hospital del Mar have designed a new method to classify the types of knee osteoarthritis that patients suffer from in a more objective and precise way.
27/06/2024 - Press release
Gastric bypass is more effective than the other common approach, vertical sleeve gastrectomy, in reducing LDL cholesterol levels. This is a common comorbidity in patients undergoing this type of surgery and a primary agent causing atherosclerosis. This is revealed in a study by the Bariatric Surgery Unit at Hospital del Mar, published in the journal Cardiovascular Diabetology. The study's authors argue that this fact should be considered when deciding which technique to use for each patient.
05/06/2024 - Press release
A scientific team led by Dr Anna Bigas, from the Hospital del Mar Research Institute and the Josep Carreras Institute, has described the role of the IκBα protein in the differentiation process of haematopoietic cells. In the absence of this protein, the stem cells enter quiescence, acquire a dormant state and maintain their potential, which may allow them to be transplanted for therapeutic uses in leukaemia or blood diseases of genetic origin. This is an important step towards being able to generate these types of cells in the lab, preventing them from differentiating and turning into other cells too early.
29/05/2024 - Press release
An international study led by the Hospital del Mar Medical Research Institute has demonstrated, for the first time, the role of two proteins in the activation and deactivation of the system through which drugs act against schizophrenia symptoms. These two proteins are potential targets for developing new drugs aimed at specific symptoms of the disease, avoiding the side effects of current treatments. The study analyzed how certain molecules act on a serotonin cell receptor, which could allow for differentiated effects on schizophrenia symptoms without affecting other brain processes.
Més informació "New Avenues to Developing Personalized Treatments for Schizophrenia"
21/05/2024 - Press release
A systematic review and meta-analysis of the scientific evidence published between 2000 and 2021 estimates the recurrence risk in people who have suffered a minor stroke, a stroke that does not cause sequelae. The study is published by the Journal of the American Heart Association and includes participation from the Neurology Service of Hospital del Mar. Almost one in ten people who suffer a stroke without sequelae, known as a minor stroke, will experience a second stroke within three months of the first episode. This is established by a recent study led by researchers from the University of Melbourne in Australia, with participation from the Neurology Service of Hospital del Mar. The work, a systematic review and meta-analysis of 14 publications on the subject, is published by the Journal of the American Heart Association. It is the largest study on this type of pathology conducted to date.
14/05/2024 - Press release
Individuals hospitalized for acute exacerbations of chronic obstructive pulmonary disease (COPD) exhibit elevated blood levels of proteins that promote blood clotting, according to a study from Hospital del Mar published in ERJ Open Research. This increases their risk of cardiovascular complications. For this reason, the authors of the study recommend that these patients always receive systematic and preventative anticoagulant treatment during their hospital stay. The same study also points out the need for rigorous monitoring of people with COPD who experience three or more exacerbations per year, as their blood protein profile when stable is very similar to that of individuals hospitalized for this condition.
06/05/2024 - Press release
Dr. Torrens is a Professor of Psychiatry, while Dr. Pujol is a Professor of Dermatology. Both at the Department of Medicine and Health Sciences of UPF. Dr. Marta Torrens, emeritus director of Addiction at Hospital del Mar, has been appointed Professor of Psychiatry at the Department of Medicine and Health Sciences of Pompeu Fabra University since April 16, after successfully passing the opposition process. Dr. Torrens also serves as the coordinator of the Addiction Research Group at the center's Research Institute. Dr. Ramon M. Pujol, head of the Dermatology Service at the hospital and coordinator of the Research Group on Inflammatory and Neoplastic Dermatologic Diseases at the Hospital del Mar Research Institute, won the competition for the position of Professor of Dermatology at UPF on April 17.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
